-
Something wrong with this record ?
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality
E. Zolotov, A. Sigal, M. Havrda, M. Raskova, D. Girsa, U. Hochfeld, K. Krátká, I. Rychlík
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2010
ProQuest Central
from 1994-05-01 to 1 year ago
ProQuest Central
from 2017-01-01
Open Access Digital Library
from 2013-01-01
Medline Complete (EBSCOhost)
from 2005-01-01
Health & Medicine (ProQuest)
from 1994-05-01 to 1 year ago
Health & Medicine (ProQuest)
from 2017-01-01
Karger Open Access
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
PubMed
37166324
DOI
10.1159/000530803
Knihovny.cz E-resources
- MeSH
- Acute Kidney Injury * MeSH
- Renal Insufficiency, Chronic * MeSH
- COVID-19 * MeSH
- Humans MeSH
- Hospital Mortality MeSH
- Lung diagnostic imaging MeSH
- Prognosis MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: The main objective of this study was to identify the best combination of admission day parameters for predicting COVID-19 mortality in hospitalized patients. Furthermore, we sought to compare the predictive capacity of pulmonary parameters to that of renal parameters for mortality from COVID-19. METHODS: In this retrospective study, all patients admitted to a tertiary hospital between September 1st, 2020, and December 31st, 2020, who were clinically symptomatic and tested positive for COVID-19, were included. We gathered extensive data on patient admissions, including laboratory results, comorbidities, chest X-ray (CXR) images, and SpO2 levels, to determine their role in predicting mortality. Experienced radiologists evaluated the CXR images and assigned a score from 0 to 18 based on the severity of COVID-19 pneumonia. Further, we categorized patients into two independent groups based on their renal function using the RIFLE and KDIGO criteria to define the acute kidney injury (AKI) and chronic kidney disease (CKD) groups. The first group ("AKI&CKD") was subdivided into six subgroups: normal renal function (A); CKD grade 2+3a (B); AKI-DROP (C); CKD grade 3b (D); AKI-RISE (E); and grade 4 + 5 CKD (F). The second group was based only on estimated glomerular filtration rate (eGFR) at the admission, and thus it was divided into four grades: grade 1, grade 2+3a, grade 3b, and grade 4 + 5. RESULTS: The cohort comprised 619 patients. Patients who died during hospitalization had a significantly higher mean radiological score compared to those who survived, with a p value <0.01. Moreover, we observed that the risk for mortality was significantly increased as renal function deteriorated, as evidenced by the AKI&CKD and eGFR groups (p < 0.001 for each group). Regarding mortality prediction, the area under the curve (AUC) for renal parameters (AKI&CKD group, eGFR group, and age) was found to be superior to that of pulmonary parameters (age, radiological score, SpO2, CRP, and D-dimer) with an AUC of 0.8068 versus 0.7667. However, when renal and pulmonary parameters were combined, the AUC increased to 0.8813. Optimal parameter combinations for predicting mortality from COVID-19 were identified for three medical settings: Emergency Medical Service (EMS), the Emergency Department, and the Internal Medicine Floor. The AUC for these settings was 0.7874, 0.8614, and 0.8813, respectively. CONCLUSIONS: Our study demonstrated that selected renal parameters are superior to pulmonary parameters in predicting COVID-19 mortality for patients requiring hospitalization. When combining both renal and pulmonary factors, the predictive ability of mortality significantly improved. Additionally, we identified the optimal combination of factors for mortality prediction in three distinct settings: EMS, Emergency Department, and Internal Medicine Floor.
2nd Faculty of Medicine Charles University Prague Czechia
3rd Faculty of Medicine Charles University Prague Czechia
Department of Internal Medicine Faculty Hospital Královské Vinohrady Prague Czechia
Department of Radiology Faculty Hospital Královské Vinohrady Prague Czechia
Internal Medicine Department Hackensack University Medical Center Hackensack New Jersey USA
Pediatrics Department Hackensack University Medical Center Hackensack New Jersey USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001318
- 003
- CZ-PrNML
- 005
- 20240213094539.0
- 007
- ta
- 008
- 240109s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000530803 $2 doi
- 035 __
- $a (PubMed)37166324
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Zolotov, Eli $u Internal Medicine Department, Hackensack University Medical Center, Hackensack, New Jersey, USA, elizolotov@gmail.com $u Third Faculty of Medicine, Charles University, Prague, Czechia, elizolotov@gmail.com
- 245 10
- $a Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality / $c E. Zolotov, A. Sigal, M. Havrda, M. Raskova, D. Girsa, U. Hochfeld, K. Krátká, I. Rychlík
- 520 9_
- $a INTRODUCTION: The main objective of this study was to identify the best combination of admission day parameters for predicting COVID-19 mortality in hospitalized patients. Furthermore, we sought to compare the predictive capacity of pulmonary parameters to that of renal parameters for mortality from COVID-19. METHODS: In this retrospective study, all patients admitted to a tertiary hospital between September 1st, 2020, and December 31st, 2020, who were clinically symptomatic and tested positive for COVID-19, were included. We gathered extensive data on patient admissions, including laboratory results, comorbidities, chest X-ray (CXR) images, and SpO2 levels, to determine their role in predicting mortality. Experienced radiologists evaluated the CXR images and assigned a score from 0 to 18 based on the severity of COVID-19 pneumonia. Further, we categorized patients into two independent groups based on their renal function using the RIFLE and KDIGO criteria to define the acute kidney injury (AKI) and chronic kidney disease (CKD) groups. The first group ("AKI&CKD") was subdivided into six subgroups: normal renal function (A); CKD grade 2+3a (B); AKI-DROP (C); CKD grade 3b (D); AKI-RISE (E); and grade 4 + 5 CKD (F). The second group was based only on estimated glomerular filtration rate (eGFR) at the admission, and thus it was divided into four grades: grade 1, grade 2+3a, grade 3b, and grade 4 + 5. RESULTS: The cohort comprised 619 patients. Patients who died during hospitalization had a significantly higher mean radiological score compared to those who survived, with a p value <0.01. Moreover, we observed that the risk for mortality was significantly increased as renal function deteriorated, as evidenced by the AKI&CKD and eGFR groups (p < 0.001 for each group). Regarding mortality prediction, the area under the curve (AUC) for renal parameters (AKI&CKD group, eGFR group, and age) was found to be superior to that of pulmonary parameters (age, radiological score, SpO2, CRP, and D-dimer) with an AUC of 0.8068 versus 0.7667. However, when renal and pulmonary parameters were combined, the AUC increased to 0.8813. Optimal parameter combinations for predicting mortality from COVID-19 were identified for three medical settings: Emergency Medical Service (EMS), the Emergency Department, and the Internal Medicine Floor. The AUC for these settings was 0.7874, 0.8614, and 0.8813, respectively. CONCLUSIONS: Our study demonstrated that selected renal parameters are superior to pulmonary parameters in predicting COVID-19 mortality for patients requiring hospitalization. When combining both renal and pulmonary factors, the predictive ability of mortality significantly improved. Additionally, we identified the optimal combination of factors for mortality prediction in three distinct settings: EMS, Emergency Department, and Internal Medicine Floor.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a akutní poškození ledvin $7 D058186
- 650 12
- $a chronická renální insuficience $7 D051436
- 650 _2
- $a plíce $x diagnostické zobrazování $7 D008168
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a mortalita v nemocnicích $7 D017052
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sigal, Anat $u Third Faculty of Medicine, Charles University, Prague, Czechia $u Pediatrics Department, Hackensack University Medical Center, Hackensack, New Jersey, USA
- 700 1_
- $a Havrda, Martin $u Department of Internal Medicine, Faculty Hospital Královské Vinohrady, Prague, Czechia
- 700 1_
- $a Raskova, Maria $u Department of Radiology, Faculty Hospital Královské Vinohrady, Prague, Czechia
- 700 1_
- $a Girsa, David $u Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Radiology, Faculty Hospital Královské Vinohrady, Prague, Czechia $u Second Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Hochfeld, Uri $u Internal Medicine Department, Hackensack University Medical Center, Hackensack, New Jersey, USA
- 700 1_
- $a Krátká, Karolína $u Department of Internal Medicine, Faculty Hospital Královské Vinohrady, Prague, Czechia
- 700 1_
- $a Rychlík, Ivan $u Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Internal Medicine, Faculty Hospital Královské Vinohrady, Prague, Czechia
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 48, č. 1 (2023), s. 347-356
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37166324 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094536 $b ABA008
- 999 __
- $a ok $b bmc $g 2049759 $s 1211012
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 48 $c 1 $d 347-356 $e 20230425 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- LZP __
- $a Pubmed-20240109